Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Neurobiology of Disease|March 23, 2021
Inhibition of GSK-3 ameliorates the pathogenesis of Huntington's diseaseIdo Rippin, Katherina Bonder, Shirley Joseph, et al.
Biological Psychiatry|March 31, 2004
Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampusOksana Kaidanovich-Beilin, Anat Milman, Abraham Weizman, et al.
Journal of Molecular Neuroscience : MN|October 1, 2004
Lithium-mediated phosphorylation of glycogen synthase kinase-3beta involves PI3 kinase-dependent activation of protein kinase C-alphaNoa Kirshenboim, Batya Plotkin, Shani Ben Shlomo, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 21, 2016
Up-regulation of insulin-like growth factor 2 by ketamine requires glycogen synthase kinase-3 inhibitionSteven F Grieco, Yuyan Cheng, Hagit Eldar-Finkelman, et al.
Molecular and Cellular Neurosciences|August 17, 2010
Identification of eukaryotic elongation factor-2 as a novel cellular target of lithium and glycogen synthase kinase-3Racheli Karyo, Yael Eskira, Albert Pinhasov, et al.
Molecular and Cellular Neurosciences|February 10, 2007
Role of glycogen synthase kinase-3beta in early depressive behavior induced by mild traumatic brain injuryMoran Shapira, Avital Licht, Anat Milman, et al.
The Journal of Biological Chemistry|November 17, 2012
Inhibition of glycogen synthase kinase-3 ameliorates β-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studiesLimor Avrahami, Dorit Farfara, Maya Shaham-Kol, et al.
Free Radical Biology & Medicine|August 15, 2025
HDAC inhibition protects RPE cells from oxidative stress via enhanced mitochondrial fusion, cytoskeletal repair, and Nrf-2 activationYarine Lugassy, Eva Berent, Lotan Tarnoy, et al.
Science Signaling|December 1, 2016
A unique type of GSK-3 inhibitor brings new opportunities to the clinicAvital Licht-Murava, Rom Paz, Lilach Vaks, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 26, 2024
Small molecule modulation of p75<sup>NTR</sup> engages the autophagy-lysosomal pathway and reduces huntingtin aggregates in cellular and mouse models of Huntington's diseaseDanielle A Simmons, Namitha Alexander, Gloria Cao, et al.
Pageof 6